Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jiangxi Institute of Biological ProductsHKSE:06915 +1.33%23 Interest Coverage is 3,120.18 as of Dec. 2025, which is 4154% above its 10-year median of 73.35. GuruFocus rates HKSE:06915 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review. Among 677 Drug Manufacturers companies, Jiangxi Institute of Biological Products ranks better than 95.13% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Jiangxi Institute of Biological Products's
Operating Income
for the
six
months ended in Dec. 2025 was HK$118.6 Mil. Jiangxi Institute of Biological Products's Interest Expense for the
six
months ended in Dec. 2025 was HK$-0.0 Mil.
Jiangxi Institute of Biological Products's interest coverage for the quarter that ended in Dec. 2025 was 3,120.18.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Jiangxi Institute of Biological Products Inc has enough cash to cover all of its debt. Its financial situation is stable.
HKSE:06915'
s Interest Coverage Range Over the Past 10 Years
Min: 37.92 Med: 73.35 Max: 3120.18
Current: 3120.18
HKSE:06915's Interest Coverage is ranked better than 95.13% of 677
companies
in the Drug Manufacturers industry
Industry Median: 12.99
vs HKSE:06915: 3120.18
Jiangxi Institute of Biological Products (HKSE:06915) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Jiangxi Institute of Biological Products Interest Coverage Related Terms
Jiangxi Institute of Biological Products Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Jiangxi Institute of Biological Products Interest Coverage Chart
Jiangxi Institute of Biological Products Annual Data
Trend
Dec23
Dec24
Dec25
Interest Coverage
73.35
37.92
3,120.18
Jiangxi Institute of Biological Products Semi-Annual Data
Dec23
Dec24
Dec25
Interest Coverage
73.35
37.92
3,120.18
HKSE:06915 vs LLY, JNJ, ABBV: Interest Coverage Comparison
For the Drug Manufacturers - General subindustry, Jiangxi Institute of Biological Products's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangxi Institute of Biological Products Interest Coverage vs Drug Manufacturers Industry
Jiangxi Institute of Biological Products Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Institute of Biological Products (HKSE:06915) has a Interest Coverage of 3,120.18 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Jiangxi Institute of Biological Products and its competitors. This is 4154% above median its historical median of 73.35. Over the past decade, Jiangxi Institute of Biological Products' Interest Coverage has ranged from 37.92 to 3,120.18. According to the industry distribution chart, Jiangxi Institute of Biological Products ranks #33 out of 677 companies in the Drug Manufacturers industry, placing it in the top 4.9%.
Is Jiangxi Institute of Biological Products' Interest Coverage too high?
Jiangxi Institute of Biological Products' current Interest Coverage of 3,120.18 is 4154% above median its 10-year median of 73.35. Over the past 10 years, this metric has ranged from a low of 37.92 to a high of 3,120.18. The Drug Manufacturers industry median Interest Coverage is 12.99. Jiangxi Institute of Biological Products' value of 3,120.18 is 23919.9% above this industry median. Based on the distribution chart, Jiangxi Institute of Biological Products ranks #33 out of 677 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jiangxi Institute of Biological Products has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Institute of Biological Products' Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Jiangxi Institute of Biological Products ranks #33 out of 677 companies for Interest Coverage. This places Jiangxi Institute of Biological Products in the top 5% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.99. Jiangxi Institute of Biological Products' value of 3,120.18 is 23919.9% above this benchmark. Historically, Jiangxi Institute of Biological Products' own Interest Coverage has ranged from 37.92 to 3,120.18 over the past decade. While the company's 10-year median is 73.35 vs. the industry median of 12.99, Jiangxi Institute of Biological Products has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.99, based on 677 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangxi Institute of Biological Products's current Interest Coverage of 3,120.18 is 23919.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Jiangxi Institute of Biological Products and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangxi Institute of Biological Products's current Interest Coverage is 3,120.18, which is 4154% above median its own 10-year median of 73.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Institute of Biological Products stock overvalued right now?
Jiangxi Institute of Biological Products (HKSE:06915) has a current Interest Coverage of 3,120.18. The current Interest Coverage is 3,120.18, which is 4154% above median its 10-year median of 73.35 and 23919.9% above the Drug Manufacturers industry median of 12.99. Jiangxi Institute of Biological Products' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Jiangxi Institute of Biological Products (HKSE:06915), the current Interest Coverage is 3,120.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jiangxi Institute of Biological Products Inc is principally engaged in the business of research and development, and production and sale of human tetanus antitoxin. It operates as the provider and exporter of Human TAT in China and an antiserum platform company. Its products include biological products containing immunoglobulins or immunoglobulin F(ab')2 fragments, which are used in medical applications such as tetanus, snakebite envenoming, and rabies treatment. The majority of the company's revenue is derived from the sale of Human Tetanus Antitoxin in the Chinese mainland.
23GF Score
Get the complete analysis for HKSE:06915
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06915 has been successfully added to your 
